Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
F

FDMT

Nasdaq

4D Molecular Therapeutics, Inc.

Latest disclosureSeptember 22, 2026
Insider score Why 0?
0/ 100
Qualifying buys · 30d
$0

0 purchases · 16 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 42

Limited filing history
All42Buying0Selling16Other26
Filters

Last 30 daysNo qualifying insider buying. Sales: $833.32K by 2 insiders.

42 trades · March 25, 2026 – September 16, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 20 trades on this page.

Exercise or conversion

Scott Bizily

Chief Legal Officer

Common Stock

Value context
$6.77K
Reported price
$4.14 / share
Traded September 16, 2026Filed September 22, 2026SEC filing
Sale disclosed

Scott Bizily

Chief Legal Officer

Common Stock

Reported value
$22.32K
Reported price
$13.65 / share
Traded September 16, 2026Filed September 22, 2026SEC filing
Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Source
SEC EDGAR · Form 4
Issuer CIK
0001650648
Latest public acceptance
Sep 22, 2026, 10:43 PM UTC
Score calculated
Oct 6, 2026, 07:06 AM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.

Exercise or conversion

Scott Bizily

Chief Legal Officer

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$4.14 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 16, 2026Filed September 22, 2026SEC filing
Sale disclosed

David Kirn

See Remarks

Common Stock

Reported value
$811K
Reported price
$13.903 / share
Traded September 14, 2026Filed September 16, 2026SEC filing
Exercise or conversion

Scott Bizily

Chief Legal Officer

Common Stock

Value context
$3.79K
Reported price
$6.49 / share
Traded September 1, 2026Filed September 3, 2026SEC filing
Sale disclosed

Scott Bizily

Chief Legal Officer

Common Stock

Reported value
$8.18K
Reported price
$14.00 / share
Traded September 1, 2026Filed September 3, 2026SEC filing
Exercise or conversion

Scott Bizily

Chief Legal Officer

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$6.49 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 1, 2026Filed September 3, 2026SEC filing
Exercise or conversion

David Kirn

See Remarks

Common Stock

Value context
$207K
Reported price
$4.14 / share
Traded August 19, 2026Filed August 21, 2026SEC filing
Sale disclosed

David Kirn

See Remarks

Common Stock

Reported value
$662.62K
Reported price
$15.3566 / share
Traded August 19, 2026Filed August 21, 2026SEC filing
Sale disclosed

David Kirn

See Remarks

Common Stock

Reported value
$425.65K
Reported price
$16.4173 / share
Traded August 19, 2026Filed August 21, 2026SEC filing
Exercise or conversion

David Kirn

See Remarks

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$4.14 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded August 19, 2026Filed August 21, 2026SEC filing
Exercise or conversion

Scott Bizily

Chief Legal Officer

Common Stock

Value context
$6.77K
Reported price
$4.14 / share
Traded August 13, 2026Filed August 17, 2026SEC filing
Sale disclosed

Scott Bizily

Chief Legal Officer

Common Stock

Reported value
$19.62K
Reported price
$12.00 / share
Traded August 13, 2026Filed August 17, 2026SEC filing
Exercise or conversion

Scott Bizily

Chief Legal Officer

Common Stock

Value context
$6.77K
Reported price
$4.14 / share
Traded August 17, 2026Filed August 17, 2026SEC filing
Sale disclosed

Scott Bizily

Chief Legal Officer

Common Stock

Reported value
$19.95K
Reported price
$12.20 / share
Traded August 17, 2026Filed August 17, 2026SEC filing
Exercise or conversion

Scott Bizily

Chief Legal Officer

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$4.14 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded August 13, 2026Filed August 17, 2026SEC filing
Exercise or conversion

Scott Bizily

Chief Legal Officer

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$4.14 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded August 17, 2026Filed August 17, 2026SEC filing
Sale disclosed

David Kirn

See Remarks

Common Stock

Reported value
$274.6K
Reported price
$10.2301 / share
Traded August 4, 2026Filed August 5, 2026SEC filing
Sale disclosed

David Kirn

See Remarks

Common Stock

Reported value
$124.72K
Reported price
$10.0461 / share
Traded August 3, 2026Filed August 4, 2026SEC filing
Sale disclosed

David Kirn

See Remarks

Common Stock

Reported value
$548.18K
Reported price
$12.8656 / share
Traded July 9, 2026Filed July 14, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
Chief Legal OfficerCommon StockOption exercise or conversion10b5-11,635$4.14 / share$6.77KSep 16Filed Sep 22 · 6d laterSEC filing
Chief Legal OfficerCommon StockSale10b5-11,635$13.65 / share$22.32KSep 16Filed Sep 22 · 6d laterSEC filing
Chief Legal OfficerStock Option (Right to Buy)Option exercise or conversion10b5-1Derivative units1,635$4.14 exercise / conversion priceNot a separate purchaseSep 16Filed Sep 22 · 6d laterSEC filing
See RemarksCommon StockSale10b5-158,333$13.90 / share$811KSep 14Filed Sep 16 · 2d laterSEC filing
Chief Legal OfficerCommon StockOption exercise or conversion10b5-1584$6.49 / share$3.79KSep 1Filed Sep 3 · 2d laterSEC filing
Chief Legal OfficerCommon StockSale10b5-1584$14.00 / share$8.18KSep 1Filed Sep 3 · 2d laterSEC filing
Chief Legal OfficerStock Option (Right to Buy)Option exercise or conversion10b5-1Derivative units584$6.49 exercise / conversion priceNot a separate purchaseSep 1Filed Sep 3 · 2d laterSEC filing
See RemarksCommon StockOption exercise or conversion10b5-150,000$4.14 / share$207KAug 19Filed Aug 21 · 2d laterSEC filing
See RemarksCommon StockSale10b5-12 trades69,076avg $15.75 / share$1.09MAug 19Filed Aug 21 · 2d later
2 filings
  • 43,149 @ $15.36 · $662.62KSEC filing
  • 25,927 @ $16.42 · $425.65KSEC filing
See RemarksStock Option (Right to Buy)Option exercise or conversion10b5-1Derivative units50,000$4.14 exercise / conversion priceNot a separate purchaseAug 19Filed Aug 21 · 2d laterSEC filing
Chief Legal OfficerCommon StockOption exercise or conversion10b5-11,635$4.14 / share$6.77KAug 13Filed Aug 17 · 4d laterSEC filing
Chief Legal OfficerCommon StockSale10b5-11,635$12.00 / share$19.62KAug 13Filed Aug 17 · 4d laterSEC filing
Chief Legal OfficerCommon StockOption exercise or conversion10b5-11,635$4.14 / share$6.77KAug 17Filed Aug 17 · 0d laterSEC filing
Chief Legal OfficerCommon StockSale10b5-11,635$12.20 / share$19.95KAug 17Filed Aug 17 · 0d laterSEC filing
Chief Legal OfficerStock Option (Right to Buy)Option exercise or conversion10b5-1Derivative units1,635$4.14 exercise / conversion priceNot a separate purchaseAug 13Filed Aug 17 · 4d laterSEC filing
Chief Legal OfficerStock Option (Right to Buy)Option exercise or conversion10b5-1Derivative units1,635$4.14 exercise / conversion priceNot a separate purchaseAug 17Filed Aug 17 · 0d laterSEC filing
See RemarksCommon StockSale10b5-126,842$10.23 / share$274.6KAug 4Filed Aug 5 · 1d laterSEC filing
See RemarksCommon StockSale10b5-112,415$10.05 / share$124.72KAug 3Filed Aug 4 · 1d laterSEC filing
See RemarksCommon StockSale10b5-142,608$12.87 / share$548.18KJul 9Filed Jul 14 · 5d laterSEC filing

Showing the latest 20 of 42 trades. Show all 42 trades

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Congress transactions 0

All Congress filings
No disclosed congressional trades for FDMT in the imported filings.

This reflects the filings imported so far, not a complete trading history.